Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine. [electronic resource]
Producer: 20040224Description: 403-15 p. digitalISSN:- 0732-183X
- Adjuvants, Immunologic
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Alkylating -- administration & dosage
- Cancer Vaccines -- therapeutic use
- Combined Modality Therapy
- Cyclophosphamide -- therapeutic use
- Dinitrobenzenes -- immunology
- Female
- Follow-Up Studies
- Haptens
- Humans
- Hypersensitivity, Delayed -- immunology
- Male
- Melanoma -- drug therapy
- Middle Aged
- Mycobacterium bovis
- Neoplasm Recurrence, Local -- drug therapy
- Skin Neoplasms -- drug therapy
- Survival Rate
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.